First drug for rare skin cancer wins approval FDA approved the first treatment for metastatic Merkel cell carcinoma (MCC), a rare, aggressive skin cancer. 9 Newly Approved Novel Drugs March 24, 2017 By Nicholas Hamm It's still early in 2017, but the FDA has been approving drugs left and right. Here's what you need to know. How to target high-risk populations with behavioral health March 23, 2017 By Ron Geraty MD Here are four of the top benefits of incorporating behavioral health management into care management plans for members with chronic conditions. Five pharmacy regulations health execs must keep on their radars in 2017 March 19, 2017 By Kenneth Maxik Here are five critical regulations that executives can begin to prepare for today. Walgreens Program Creates Cancer-Specialized Locations March 15, 2017 By Christine Blank How Walgreens is helping pharmacists be more involved than ever in helping cancer patients. New strategies for managing drug spend: RA, Cancer, Hep C March 04, 2017 The proliferation of specialty drugs has prompted new techniques for keeping costs in tow. Pearls for better diagnosis, treatment of red eye February 15, 2017 By Vanessa Caceres Ophthalmologists should consider various potential problems, including a number of systemic conditions and infections, when examining a rare or persistent red eye. How precision medicine is improving patient lives: Real examples January 29, 2017 By Tracey Walker An expert at the Precision Medicine World Conference shared cancer patient perspectives on the importance of immuno-oncology and breakthrough targeted therapies and how they have extended their lives. Top challenges in cancer care January 14, 2017 By Tracey Walker Cancer drug costs remain the most critical challenge in care, among other things. Three issues to watch at the J.P. Morgan Healthcare Conference 2017 January 03, 2017 By Marc O'Connor This year’s J.P. Morgan Healthcare Conference will address some of the biggest managed care trends, including next-gen at-risk contracts and access to therapy as cancer trends towards a chronic condition.